tiprankstipranks
Trending News
More News >
Opus Genetics (IRD)
NASDAQ:IRD
US Market

Opus Genetics (IRD) Financial Statements

Compare
1,023 Followers

Opus Genetics Financial Overview

Opus Genetics's market cap is currently $60.85M. The company's EPS TTM is $-0.24; its P/E ratio is ―; Opus Genetics is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 10.99M$ 19.05M$ 39.85M$ 589.00K$ 0.00
Gross Profit$ 10.98M$ 19.05M$ 39.85M$ 589.00K$ 0.00
Operating Income$ -62.07M$ -10.56M$ 18.23M$ -22.70M$ -19.97M
EBITDA$ -57.52M$ -9.97M$ 18.22M$ -56.69M$ -17.77M
Net Income$ -57.53M$ -9.99M$ 17.89M$ -56.69M$ -24.62M
Balance Sheet
Cash & Short-Term Investments$ 30.32M$ 50.52M$ 42.68M$ 24.75M$ 16.40M
Total Assets$ 36.86M$ 53.95M$ 48.99M$ 26.08M$ 17.68M
Total Debt$ 0.00$ 0.00$ 0.00$ 538.00K$ 0.00
Net Debt$ -30.32M$ -50.50M$ -42.63M$ -24.00M$ -16.40M
Total Liabilities$ 30.14M$ 4.04M$ 2.75M$ 3.85M$ 31.15M
Stockholders' Equity$ 6.72M$ 49.91M$ 46.24M$ 22.22M$ -13.47M
Cash Flow
Free Cash Flow$ -25.58M$ -1.11M$ 14.31M$ -19.37M$ -6.80M
Operating Cash Flow$ -25.58M$ -1.11M$ 14.31M$ -19.37M$ -6.80M
Investing Cash Flow$ 1.21M$ 0.00$ 0.00$ -100.00K$ 539.00K
Financing Cash Flow$ 4.19M$ 8.98M$ 3.79M$ 27.61M$ 21.12M
Currency in USD

Opus Genetics Earnings and Revenue History

Opus Genetics Debt to Assets

Opus Genetics Cash Flow

Opus Genetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis